Ren Doctor Chief Physician

The First Affiliated Hospital, Sun Yat-sen University · Department of Radiation Oncology · Chief Physician

A radiation oncologist with 15+ years of experience at Sun Yat-sen University, currently an Associate Chief Physician. Holds leadership roles in Guangdong medical associations, has published 19 papers, and leads research on gemcitabine-activated EB virus replication and DNA-PKcs gene knockout effects.

Medical Expertise: Extensive clinical experience and research foundation in comprehensive cancer treatment for thoracic tumors (lung cancer, breast cancer, esophageal cancer), abdominal tumors (gastric cancer, colorectal cancer), and head and neck cancers. Specializes in radiotherapy for urological tumors (bladder, prostate, kidney tumors) and gynecological tumors (cervical cancer, endometrial cancer, etc.). Research Focus: Comprehensive treatment of urological tumors and gynecological tumors.

Ren Doctor
Doctor Photo
Basic Information

About Dr. Ren Doctor

Hospital
The First Affiliated Hospital, Sun Yat-sen University
Title
Chief Physician
Department
Department of Radiation Oncology
Years of Practice
28 years (1998 — present)
**Education and Professional Experience:** 2008.07-2011.07 Sun Yat-sen University Cancer Center, Department of Radiation Oncology, Resident Physician 2011.07-2017.12 The First Affiliated Hospital, Sun Yat-sen University, Department of Radiation Oncology, Attending Physician 2017.12-Present The First Affiliated Hospital, Sun Yat-sen University, Department of Radiation Oncology, Associate Chief Physician **Professional Affiliations:** Standing Committee Member, Oncology Professional Committee, Guangdong Provincial Clinical Medical Association Standing Committee Member, Multidisciplinary Comprehensive Diagnosis and Treatment of Tumors Professional Committee, Guangdong Provincial Primary Medical Association **Publications:** Published 19 papers in domestic and international academic journals as first author (including co-first author) and corresponding author (including co-corresponding author). Participated in and led multiple projects funded by the National Natural Science Foundation of China, Provincial Science and Technology Plans, and Departmental/ Bureau-level Scientific Research Projects. **Current Research Projects:** 1. Molecular mechanism of gemcitabine (GEM) activating EB virus lytic replication, Guangdong Provincial Medical Science and Technology Research Fund Project 2. Study on the effect of DNA-PKcs gene knockout and its inhibitor on non-homologous end joining repair of DNA double-strand breaks, National Natural Science Foundation of China **Major Publications (First/Co-first/Corresponding Author):** (1) YuFeng Ren, YuanHong Gao, XinPing Cao,et al., 3D-CT implanted interstitial brachytherapy for T2b NPC. Radiation Oncology 2010, 5:113 (2) YuFeng Ren, Yanfang Li, Jihong Liu. A modified shorten administration schedule for neoadjuvant chemotherapy with irinotecan and cisplatin in locally advanced cervical cancer. Int J Gynecol Cancer 2011;21: 685-689 (3) YuFeng Ren, XinPing Cao, Jia Xu,et al.,3D-image-guided high-dose-rate intracavitary brachytherapy for salvage treatment of locally persistent NPC. Radiation Oncology 2013,8:165 (4) Yan Xiong, YuFeng Ren, Jia Xu, et al.,.Enhanced external counterpulsation inhibits endothelial apoptosis via modulation of BIRC2 and Apaf-1 genes in porcine hypercholesterolemia. Int J Cardiol 2013, 11: 033 (5) YuFeng Ren, QuanCheng Zhao, Hui Liu,et al.,3D-image-guided HDR-BT versus 2D HDR-BT after external beam radiotherapy for early T-stage NPC.BMC Cancer.2014, 14:894 (6) Jia Xu, YuFeng Ren, Xue Xu,et al., Schistosoma japonicum tegumental protein 20.8role in reproduction through its calcium binding ability. Parasitol Res,2014,113:491–497 (7) Sangang Wu, Juan Zhou, YuFeng Ren,et al., Tumor location is a prognostic factor for survival of Chinese women with T1-2N0M0 breast cancer. International Journal of Surgery 2014,12:394 (8) YuFeng Ren, Huizhi Qiu, Yujie Yuan, ,et al.,Evaluation of 7th Edition of AJCC Staging System for Nasopharyngeal Carcinoma.Journal of Cancer.2017,8(9):1665 (9) Jinning Ye, Yufeng Ren, Jianhui Chen,et al., Prognostic Significance of Preoperative and Postoperative Complement C3 Depletion in Gastric Cancer: A Three-Year Survival Investigation. BioMed Research International. 2017(2)14. (10) Li Ma, Guang, Yu Luo, YuFeng Ren, ,et al.,Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.CJC.(2017) 36:8 (11) Shaoqing Niu, Ge Wen, Yufeng Ren,et al., Predictive Value of Primary TumorSite for LocoregionalRecurrence in Early Breast Cancer Patients with One toThree Positive Axillary Lymphadenophy. Journal of Cancer 2017,(4).8 (12) Jun D,Tian Z,Yufeng Ren,et al.,Inhibiting DNA-PKcs in a non-homologus end-joining pathway in response to DNA double-strand breaks.Oncotarget.2017.07. (13) Ren,YF;Ye,JN;Zhang,J,et al.,Adjuvant radiation therapy for positive lymph nodes after resection of esophageal squamous cell carcinoma: Can it earn promising benefits within long-term follow-up?Annals of Oncology.(Abstract).2017:28:3:P-066 (14) Ye,JN; Ren,YF; Wang,Y,et al.,The optimal application of transrectal ultrasound in staging of rectal cancer following neoadjuvant therapy: A pragmatic study for accuracy investigation. Annals of Oncology.(Abstract).2017(28):3: P-365 (15) Y.Ren,J.Ye,W.Xiong,J,et al., Adjuvant radiotherapy for positive lymph nodes of oesophageal squamous cell carcinoma:can it earn promising benefits at long-term follow-up? Cancer Radiother, 2018:1278. (16) Yufeng Ren,Jinning Ye,Yan Wang,et al.,The Optimal Application of Transrectal Ultrasound in Staging of Rectal Cancer Following Neoadjuvant Therapy: A Pragmatic Study for Accuracy Investigation. Journal of Cancer 2018 (9) (17) Jinning Ye, Yufeng Ren, Zhewei Wei,et al., External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China. Surgical Oncology 27 (2018) 146-153. (18) Jun Dong, Yufeng Ren , Tian Zhang,,et al., Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair. ONCOLOGY REPORTS,2018 39: 912 (19) Yujie Yuan, Jinning Ye, Yufeng Ren.Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in China. Journal of Cancer.2018;9(1): 174
Schedule

Dr. Ren Doctor — Outpatient Schedule

Weekly clinic, including specialist and surgery days. Book 3-7 days in advance.

Clinic: The First Affiliated Hospital, Sun Yat-sen University · Department of Radiation Oncology
On Duty
Off Duty
Period Morning
08:00-12:00
Afternoon
14:00-17:30
Evening
18:30-20:30
Mon On Duty
09:00 - 12:00
Off Duty Off Duty
Tue Off Duty Off Duty Off Duty
Wed Off Duty Off Duty Off Duty
Thu Off Duty On Duty
14:00 - 17:00
Off Duty
Fri Off Duty Off Duty Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: Actual clinic hours are subject to the hospital's daily notice. Please call the Dovecure 24h hotline 400-888-0000 to confirm before booking.

Rationale for Precision

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Book your dedicated advisor now

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

24/7 medical consultation +86 18126771334 (iMessage)
Email Consultation cure@dovecure.com
WeChat dovecure_care
Cart
Your cart is empty
Continue shopping
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
Total {{ totalAmount }}
Checkout View Cart
Consult